Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Theagenio Cancer Hospital of Thessaloniki

Research site

Greece Alexandrou Simeonidi str 2, 54639 Thessaloniki, Greece

  • 1 trial recruiting
  • Amyloidosis · Plasma cell myeloma
  • Adult patients

About Specializations

Theagenio Cancer Hospital of Thessaloniki in Thessaloniki, Greece specialises in clinical trials of conditions such as Amyloidosis, Plasma cell myeloma, and other specialisations. This site conducts important research.

Main research areas of the site

Hematology and Oncology

The medical center is at the forefront of hematology and oncology research, focusing on innovative therapies for blood-related cancers. The center's commitment to advancing treatment options is evident through its exploration of novel maintenance therapies for conditions such as Newly Diagnosed Multiple Myeloma (NDMM).

  • Multiple Myeloma Research
  • Stem Cell Transplantation
  • Targeted Cancer Therapies

By comparing the efficacy of new therapeutic agents, the center contributes significantly to improving patient outcomes and expanding the understanding of cancer biology.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Alexandrou Simeonidi str 254639 ThessalonikiGreece
Open in maps ↗
Recruiting now
1 trial
Conditions studied
2

More sites in ThessalonikiGreece

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Plasma cell myeloma

Recruiting

Study Comparing Iberdomide and Lenalidomide for Maintenance Therapy After Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Celgene Corp.

Amyloidosis

Not yet recruiting

Evaluation of belantamab mafodotin plus drug combination in adult patients with newly diagnosed light chain amyloidosis

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years
  • Substances:Bortezomib
  • Sponsor:Glaxosmithkline Research & Development Limited
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.